CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
Clinical trial NCT04695977 · TERMINATED
Trial details
- NCT number
- NCT04695977
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2024-07-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.